{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:33:23Z","timestamp":1792704803723,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2014,1,12]],"date-time":"2014-01-12T00:00:00Z","timestamp":1389484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s10555-014-9494-4","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T11:08:05Z","timestamp":1389438485000},"page":"511-525","source":"Crossref","is-referenced-by-count":73,"title":["Integrating new discoveries into the \u201cvicious cycle\u201d paradigm of prostate to bone metastases"],"prefix":"10.1007","volume":"33","author":[{"given":"Leah M.","family":"Cook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Shay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Aruajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor C.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,12]]},"reference":[{"issue":"4","key":"9494_CR1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jcb.10662","volume":"91","author":"ET Keller","year":"2004","unstructured":"Keller, E. T., & Brown, J. (2004). Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. Journal of Cellular Biochemistry, 91(4), 718\u2013729.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"9768","key":"9494_CR2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","volume":"377","author":"K Fizazi","year":"2011","unstructured":"Fizazi, K., et al. (2011). Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet, 377(9768), 813\u2013822.","journal-title":"Lancet"},{"issue":"11","key":"9494_CR3","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.6004\/jnccn.2012.0145","volume":"10","author":"AD Choudhury","year":"2012","unstructured":"Choudhury, A. D., & Kantoff, P. W. (2012). New agents in metastatic prostate cancer. Journal of the National Comprehensive Cancer Network, 10(11), 1403\u20131409.","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"9494_CR4","doi-asserted-by":"crossref","unstructured":"Anonymous. (2013). FDA approves radiopharmaceutical for metastatic prostate cancer. Cancer Discovery, 3(7), OF1.","DOI":"10.1158\/2159-8290.CD-NB2013-088"},{"issue":"2","key":"9494_CR5","first-page":"98","volume":"8","author":"S Paget","year":"1989","unstructured":"Paget, S. (1989). The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Reviews, 8(2), 98\u2013101.","journal-title":"Cancer Metastasis Reviews"},{"issue":"6","key":"9494_CR6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccr.2011.11.002","volume":"20","author":"X Lu","year":"2011","unstructured":"Lu, X., et al. (2011). VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors. Cancer Cell, 20(6), 701\u2013714.","journal-title":"Cancer Cell"},{"issue":"6","key":"9494_CR7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang, Y., et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3(6), 537\u2013549.","journal-title":"Cancer Cell"},{"issue":"2","key":"9494_CR8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1359\/JBMR.041109","volume":"20","author":"YX Sun","year":"2005","unstructured":"Sun, Y. X., et al. (2005). Skeletal localization and neutralization of the SDF-1(CXCL12)\/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 20(2), 318\u2013329.","journal-title":"Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research"},{"issue":"4","key":"9494_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10555-006-9036-9","volume":"25","author":"RN Kaplan","year":"2006","unstructured":"Kaplan, R. N., Psaila, B., & Lyden, D. (2006). Bone marrow cells in the \u2018pre-metastatic niche\u2019: within bone and beyond. Cancer Metastasis Reviews, 25(4), 521\u2013529.","journal-title":"Cancer Metastasis Reviews"},{"issue":"7069","key":"9494_CR10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820\u2013827.","journal-title":"Nature"},{"issue":"2","key":"9494_CR11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2006.12.003","volume":"13","author":"RN Kaplan","year":"2007","unstructured":"Kaplan, R. N., Psaila, B., & Lyden, D. (2007). Niche-to-niche migration of bone-marrow-derived cells. Trends in Molecular Medicine, 13(2), 72\u201381.","journal-title":"Trends in Molecular Medicine"},{"issue":"5","key":"9494_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.20657","volume":"113","author":"A Janowska-Wieczorek","year":"2005","unstructured":"Janowska-Wieczorek, A., et al. (2005). Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. International Journal of Cancer, 113(5), 752\u2013760.","journal-title":"International Journal of Cancer"},{"issue":"6","key":"9494_CR13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine, 18(6), 883\u2013891.","journal-title":"Nature Medicine"},{"issue":"3","key":"9494_CR14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1083\/jcb.101.3.942","volume":"101","author":"BT Pan","year":"1985","unstructured":"Pan, B. T., et al. (1985). Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. The Journal of Cell Biology, 101(3), 942\u2013948.","journal-title":"The Journal of Cell Biology"},{"issue":"5730","key":"9494_CR15","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.308.5730.1862","volume":"308","author":"J Couzin","year":"2005","unstructured":"Couzin, J. (2005). Cell biology: the ins and outs of exosomes. Science, 308(5730), 1862\u20131863.","journal-title":"Science"},{"issue":"19","key":"9494_CR16","doi-asserted-by":"crossref","first-page":"9412","DOI":"10.1016\/S0021-9258(18)48095-7","volume":"262","author":"RM Johnstone","year":"1987","unstructured":"Johnstone, R. M., et al. (1987). Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). Journal of Biological Chemistry, 262(19), 9412\u20139420.","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"9494_CR17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Thery","year":"2002","unstructured":"Thery, C., Zitvogel, L., & Amigorena, S. (2002). Exosomes: composition, biogenesis and function. Nature Reviews Immunology, 2(8), 569\u2013579.","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"9494_CR18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2478\/s11658-009-0018-0","volume":"14","author":"K Schara","year":"2009","unstructured":"Schara, K., et al. (2009). Mechanisms for the formation of membranous nanostructures in cell-to-cell communication. Cellular & Molecular Biology Letters, 14(4), 636\u2013656.","journal-title":"Cellular & Molecular Biology Letters"},{"issue":"1","key":"9494_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski, M., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biology, 12(1), 19\u201330. sup pp 1\u201313.","journal-title":"Nature Cell Biology"},{"key":"9494_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-230X(04)91002-0","volume":"91","author":"BS Knudsen","year":"2004","unstructured":"Knudsen, B. S., & Edlund, M. (2004). Prostate cancer and the met hepatocyte growth factor receptor. Advances in Cancer Research, 91, 31\u201367.","journal-title":"Advances in Cancer Research"},{"issue":"5","key":"9494_CR21","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ajpath.2012.07.030","volume":"181","author":"D Vizio Di","year":"2012","unstructured":"Di Vizio, D., et al. (2012). Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. American Journal of Pathology, 181(5), 1573\u20131584.","journal-title":"American Journal of Pathology"},{"issue":"23","key":"9494_CR22","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1158\/0008-5472.CAN-10-1722","volume":"70","author":"J Webber","year":"2010","unstructured":"Webber, J., et al. (2010). Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Research, 70(23), 9621\u20139630.","journal-title":"Cancer Research"},{"issue":"5","key":"9494_CR23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10735-012-9415-1","volume":"43","author":"T Itoh","year":"2012","unstructured":"Itoh, T., et al. (2012). Microvesicles released from hormone-refractory prostate cancer cells facilitate mouse pre-osteoblast differentiation. Journal of Molecular Histology, 43(5), 509\u2013515.","journal-title":"Journal of Molecular Histology"},{"issue":"11","key":"9494_CR24","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1158\/1078-0432.CCR-13-0319","volume":"19","author":"RJ Lee","year":"2013","unstructured":"Lee, R. J., et al. (2013). A dose-ranging study of cabozantinib in men with castration-resistant prostate cancer and bone metastases. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 19(11), 3088\u20133094.","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"2","key":"9494_CR25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","volume":"18","author":"G Zhang","year":"2012","unstructured":"Zhang, G., et al. (2012). A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nature Medicine, 18(2), 307\u2013314.","journal-title":"Nature Medicine"},{"issue":"20","key":"9494_CR26","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1158\/1078-0432.CCR-11-2904","volume":"18","author":"Q Chen","year":"2012","unstructured":"Chen, Q., & Massague, J. (2012). Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis. Clinical Cancer Research, 18(20), 5520\u20135525.","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"9494_CR27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ccr.2011.08.025","volume":"20","author":"Q Chen","year":"2011","unstructured":"Chen, Q., Zhang, X. H., & Massague, J. (2011). Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell, 20(4), 538\u2013549.","journal-title":"Cancer Cell"},{"issue":"9","key":"9494_CR28","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1073\/pnas.89.9.3790","volume":"89","author":"LM Spain","year":"1992","unstructured":"Spain, L. M., & Mulligan, R. C. (1992). Purification and characterization of retrovirally transduced hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 89(9), 3790\u20133794.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"9494_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1074-7613(03)00354-6","volume":"20","author":"Y Matsuzaki","year":"2004","unstructured":"Matsuzaki, Y., et al. (2004). Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity, 20(1), 87\u201393.","journal-title":"Immunity"},{"issue":"12","key":"9494_CR30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/leu.2010.214","volume":"24","author":"JP Levesque","year":"2010","unstructured":"Levesque, J. P., Helwani, F. M., & Winkler, I. G. (2010). The endosteal \u2018osteoblastic\u2019 niche and its role in hematopoietic stem cell homing and mobilization. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK, 24(12), 1979\u20131992.","journal-title":"Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"issue":"5","key":"9494_CR31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","volume":"109","author":"B Heissig","year":"2002","unstructured":"Heissig, B., et al. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109(5), 625\u2013637.","journal-title":"Cell"},{"issue":"19","key":"9494_CR32","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/onc.2012.250","volume":"32","author":"Q Wang","year":"2013","unstructured":"Wang, Q., et al. (2013). SUMO-specific protease 1 promotes prostate cancer progression and metastasis. Oncogene, 32(19), 2493\u20132498.","journal-title":"Oncogene"},{"issue":"6","key":"9494_CR33","first-page":"1832","volume":"62","author":"RS Taichman","year":"2002","unstructured":"Taichman, R. S., et al. (2002). Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research, 62(6), 1832\u20131837.","journal-title":"Cancer Research"},{"issue":"2","key":"9494_CR34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i2.50","volume":"22","author":"C Yu","year":"2012","unstructured":"Yu, C., et al. (2012). Prostate cancer and parasitism of the bone hematopoietic stem cell niche. Critical Reviews in Eukaryotic Gene Expression, 22(2), 131\u2013148.","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"issue":"4","key":"9494_CR35","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI43414","volume":"121","author":"Y Shiozawa","year":"2011","unstructured":"Shiozawa, Y., et al. (2011). Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. Journal of Clinical Investigation, 121(4), 1298\u20131312.","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"9494_CR36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/1541-7786.MCR-11-0404","volume":"10","author":"J Joseph","year":"2012","unstructured":"Joseph, J., et al. (2012). Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype. Molecular Cancer Research, 10(3), 282\u2013292.","journal-title":"Molecular Cancer Research"},{"issue":"7","key":"9494_CR37","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.intimp.2011.01.004","volume":"11","author":"SW Kim","year":"2011","unstructured":"Kim, S. W., et al. (2011). Consistent interactions between tumor cell IL-6 and macrophage TNF-alpha enhance the growth of human prostate cancer cells in the bone of nude mouse. International Immunopharmacology, 11(7), 862\u2013872.","journal-title":"International Immunopharmacology"},{"issue":"20","key":"9494_CR38","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/onc.2010.605","volume":"30","author":"A Rojas","year":"2011","unstructured":"Rojas, A., et al. (2011). IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene, 30(20), 2345\u20132355.","journal-title":"Oncogene"},{"issue":"4","key":"9494_CR39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MOH.0b013e328338b7d5","volume":"17","author":"I Pusic","year":"2010","unstructured":"Pusic, I., & DiPersio, J. F. (2010). Update on clinical experience with AMD3100, an SDF-1\/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells. Current Opinion in Hematology, 17(4), 319\u2013326.","journal-title":"Current Opinion in Hematology"},{"issue":"3","key":"9494_CR40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/157489212801820039","volume":"7","author":"F Nigris de","year":"2012","unstructured":"de Nigris, F., et al. (2012). CXCR4 inhibitors: tumor vasculature and therapeutic challenges. Recent Patents on Anti-Cancer Drug Discovery, 7(3), 251\u2013264.","journal-title":"Recent Patents on Anti-Cancer Drug Discovery"},{"key":"9494_CR41","doi-asserted-by":"crossref","first-page":"970525","DOI":"10.1155\/2012\/970525","volume":"2012","author":"Y Peng","year":"2012","unstructured":"Peng, Y., et al. (2012). Peroxisome proliferator-activated receptor alpha plays an important role in the expression of monocyte chemoattractant protein-1 and neointimal hyperplasia after vascular injury. PPAR Research, 2012, 970525.","journal-title":"PPAR Research"},{"key":"9494_CR42","first-page":"353878","volume":"2011","author":"T Li","year":"2011","unstructured":"Li, T., & Wu, Y. (2011). Paracrine molecules of mesenchymal stem cells for hematopoietic stem cell niche. Bone Marrow Research, 2011, 353878.","journal-title":"Bone Marrow Research"},{"issue":"5411","key":"9494_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger, M. F., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143\u2013147.","journal-title":"Science"},{"issue":"7162","key":"9494_CR44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub, A. E., et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature, 449(7162), 557\u2013563.","journal-title":"Nature"},{"issue":"43","key":"9494_CR45","doi-asserted-by":"crossref","first-page":"17460","DOI":"10.1073\/pnas.1206653109","volume":"109","author":"CP El-Haibi","year":"2012","unstructured":"El-Haibi, C. P., et al. (2012). Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc Natl Acad Sci U S A, 109(43), 17460\u201317465.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9494_CR46","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ncomms2766","volume":"4","author":"Y Jung","year":"2013","unstructured":"Jung, Y., et al. (2013). Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nature Communications, 4, 1795.","journal-title":"Nature Communications"},{"key":"9494_CR47","doi-asserted-by":"crossref","unstructured":"Spaeth, E. L., et al. (2013) Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment. Cancer Research, 73, 5347\u20135359.","DOI":"10.1158\/0008-5472.CAN-13-0087"},{"issue":"8","key":"9494_CR48","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/carcin\/bgn105","volume":"29","author":"HF Yuen","year":"2008","unstructured":"Yuen, H. F., et al. (2008). TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction. Carcinogenesis, 29(8), 1509\u20131518.","journal-title":"Carcinogenesis"},{"issue":"18","key":"9494_CR49","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1158\/1078-0432.CCR-05-2722","volume":"12","author":"TK Lee","year":"2006","unstructured":"Lee, T. K., et al. (2006). Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial\u2013mesenchymal transition. Clinical Cancer Research, 12(18), 5369\u20135376.","journal-title":"Clinical Cancer Research"},{"issue":"18","key":"9494_CR50","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2008-09-176198","volume":"113","author":"K Otsu","year":"2009","unstructured":"Otsu, K., et al. (2009). Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood, 113(18), 4197\u20134205.","journal-title":"Blood"},{"issue":"6","key":"9494_CR51","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.yjmcc.2007.04.010","volume":"42","author":"M Wang","year":"2007","unstructured":"Wang, M., et al. (2007). STAT3 mediates bone marrow mesenchymal stem cell VEGF production. Journal of Molecular and Cellular Cardiology, 42(6), 1009\u20131015.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"9","key":"9494_CR52","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1172\/JCI61209","volume":"122","author":"Y Liu","year":"2012","unstructured":"Liu, Y., et al. (2012). Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. Journal of Clinical Investigation, 122(9), 3101\u20133113.","journal-title":"Journal of Clinical Investigation"},{"issue":"22","key":"9494_CR53","doi-asserted-by":"crossref","first-page":"15554","DOI":"10.1074\/jbc.M602003200","volume":"281","author":"H Okuyama","year":"2006","unstructured":"Okuyama, H., et al. (2006). Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. Journal of Biological Chemistry, 281(22), 15554\u201315563.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"9494_CR54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2008.04.032","volume":"269","author":"L Qiao","year":"2008","unstructured":"Qiao, L., et al. (2008). Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Letters, 269(1), 67\u201377.","journal-title":"Cancer Letters"},{"issue":"6","key":"9494_CR55","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/pros.21277","volume":"71","author":"NK Thudi","year":"2011","unstructured":"Thudi, N. K., et al. (2011). Dickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastases. Prostate, 71(6), 615\u2013625.","journal-title":"Prostate"},{"issue":"1","key":"9494_CR56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","volume":"19","author":"P Bianco","year":"2013","unstructured":"Bianco, P., et al. (2013). The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nature Medicine, 19(1), 35\u201342.","journal-title":"Nature Medicine"},{"issue":"5","key":"9494_CR57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/1541-7786.MCR-12-0520","volume":"11","author":"D Zheng","year":"2013","unstructured":"Zheng, D., et al. (2013). Role of WNT7B-induced noncanonical pathway in advanced prostate cancer. Molecular Cancer Research, 11(5), 482\u2013493.","journal-title":"Molecular Cancer Research"},{"key":"9494_CR58","first-page":"280386","volume":"2012","author":"MR Hoda","year":"2012","unstructured":"Hoda, M. R., et al. (2012). The adipocyte-derived hormone leptin has proliferative actions on androgen-resistant prostate cancer cells linking obesity to advanced stages of prostate cancer. Journal of Oncology, 2012, 280386.","journal-title":"Journal of Oncology"},{"key":"9494_CR59","first-page":"895045","volume":"2013","author":"Y Liu","year":"2013","unstructured":"Liu, Y., et al. (2013). Novel adipokines and bone metabolism. International Journal of Endocrinology, 2013, 895045.","journal-title":"International Journal of Endocrinology"},{"issue":"12","key":"9494_CR60","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1158\/0008-5472.CAN-12-2160","volume":"73","author":"B Sennino","year":"2013","unstructured":"Sennino, B., et al. (2013). Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice. Cancer Research, 73(12), 3692\u20133703.","journal-title":"Cancer Research"},{"issue":"3","key":"9494_CR61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-11-0240","volume":"2","author":"B Sennino","year":"2012","unstructured":"Sennino, B., et al. (2012). Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Cancer Discovery, 2(3), 270\u2013287.","journal-title":"Cancer Discovery"},{"issue":"1","key":"9494_CR62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PPO.0b013e318281e280","volume":"19","author":"RJ Lee","year":"2013","unstructured":"Lee, R. J., & Smith, M. R. (2013). Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer. Cancer Journal, 19(1), 90\u201398.","journal-title":"Cancer Journal"},{"issue":"23","key":"9494_CR63","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-09-1938","volume":"15","author":"D Chanda","year":"2009","unstructured":"Chanda, D., et al. (2009). Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(23), 7175\u20137185.","journal-title":"Clinical Cancer Research : An Official Journal of the American Association for Cancer Research"},{"issue":"2","key":"9494_CR64","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","volume":"172","author":"S Kusmartsev","year":"2004","unstructured":"Kusmartsev, S., et al. (2004). Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology, 172(2), 989\u2013999.","journal-title":"Journal of Immunology"},{"issue":"7","key":"9494_CR65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.intimp.2011.03.003","volume":"11","author":"S Ueha","year":"2011","unstructured":"Ueha, S., Shand, F. H., & Matsushima, K. (2011). Myeloid cell population dynamics in healthy and tumor-bearing mice. International Immunopharmacology, 11(7), 783\u2013788.","journal-title":"International Immunopharmacology"},{"issue":"4","key":"9494_CR66","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","volume":"185","author":"MG Lechner","year":"2010","unstructured":"Lechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010). Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. Journal of Immunology, 185(4), 2273\u20132284.","journal-title":"Journal of Immunology"},{"issue":"6","key":"9494_CR67","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2003-01-0190","volume":"102","author":"C Melani","year":"2003","unstructured":"Melani, C., et al. (2003). Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB\/c mice suppresses immune reactivity. Blood, 102(6), 2138\u20132145.","journal-title":"Blood"},{"issue":"8","key":"9494_CR68","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jbmr.154","volume":"25","author":"L Yang","year":"2010","unstructured":"Yang, L., Edwards, C. M., & Mundy, G. R. (2010). Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 25(8), 1701\u20131706.","journal-title":"Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research"},{"issue":"4","key":"9494_CR69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccr.2004.08.031","volume":"6","author":"L Yang","year":"2004","unstructured":"Yang, L., et al. (2004). Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell, 6(4), 409\u2013421.","journal-title":"Cancer Cell"},{"issue":"2","key":"9494_CR70","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-12-2202","volume":"73","author":"A Sawant","year":"2013","unstructured":"Sawant, A., et al. (2013). Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer. Cancer Research, 73(2), 672\u2013682.","journal-title":"Cancer Research"},{"issue":"11","key":"9494_CR71","doi-asserted-by":"crossref","first-page":"e48871","DOI":"10.1371\/journal.pone.0048871","volume":"7","author":"J Zhuang","year":"2012","unstructured":"Zhuang, J., et al. (2012). Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. PLoS One, 7(11), e48871.","journal-title":"PLoS One"},{"issue":"9","key":"9494_CR72","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.4161\/onci.21990","volume":"1","author":"S Danilin","year":"2012","unstructured":"Danilin, S., et al. (2012). Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction. Oncoimmunology, 1(9), 1484\u20131494.","journal-title":"Oncoimmunology"},{"issue":"8","key":"9494_CR73","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/2159-8290.CD-12-0527","volume":"3","author":"Y Pang","year":"2013","unstructured":"Pang, Y., et al. (2013). TGF-beta signaling in myeloid cells is required for tumor metastasis. Cancer Discovery, 3(8), 936\u2013951.","journal-title":"Cancer Discovery"},{"issue":"22","key":"9494_CR74","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1158\/0008-5472.CAN-07-2593","volume":"67","author":"Y Nefedova","year":"2007","unstructured":"Nefedova, Y., et al. (2007). Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Research, 67(22), 11021\u201311028.","journal-title":"Cancer Research"},{"issue":"7","key":"9494_CR75","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","volume":"71","author":"M Fujita","year":"2011","unstructured":"Fujita, M., et al. (2011). COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Research, 71(7), 2664\u20132674.","journal-title":"Cancer Research"},{"issue":"18","key":"9494_CR76","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1158\/1078-0432.CCR-05-0883","volume":"11","author":"E Suzuki","year":"2005","unstructured":"Suzuki, E., et al. (2005). Gemcitabine selectively eliminates splenic Gr-1+\/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clinical Cancer Research, 11(18), 6713\u20136721.","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"9494_CR77","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012). Coordinated regulation of myeloid cells by tumours. Nature Reviews Immunology, 12(4), 253\u2013268.","journal-title":"Nature Reviews Immunology"},{"issue":"5","key":"9494_CR78","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00262-013-1396-8","volume":"62","author":"C Iclozan","year":"2013","unstructured":"Iclozan, C., et al. (2013). Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunology, Immunotherapy : CII, 62(5), 909\u2013918.","journal-title":"Cancer Immunology, Immunotherapy : CII"},{"issue":"4","key":"9494_CR79","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/bcr3143","volume":"14","author":"BZ Qian","year":"2012","unstructured":"Qian, B. Z., & Pollard, J. W. (2012). New tricks for metastasis-associated macrophages. Breast Cancer Research, 14(4), 316.","journal-title":"Breast Cancer Research"},{"issue":"4","key":"9494_CR80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce, J. A., & Pollard, J. W. (2009). Microenvironmental regulation of metastasis. Nature Reviews Cancer, 9(4), 239\u2013252.","journal-title":"Nature Reviews Cancer"},{"issue":"3","key":"9494_CR81","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jee\/83.3.788","volume":"83","author":"BD Glofcheskie","year":"1990","unstructured":"Glofcheskie, B. D., & Surgeoner, G. A. (1990). Muscovy ducks as an adjunct for the control of the house fly (Diptera: Muscidae). Journal of Economic Entomology, 83(3), 788\u2013791.","journal-title":"Journal of Economic Entomology"},{"issue":"6","key":"9494_CR82","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1189\/jlb.0905495","volume":"80","author":"AE Dirkx","year":"2006","unstructured":"Dirkx, A. E., et al. (2006). Monocyte\/macrophage infiltration in tumors: modulators of angiogenesis. Journal of Leukocyte Biology, 80(6), 1183\u20131196.","journal-title":"Journal of Leukocyte Biology"},{"issue":"7","key":"9494_CR83","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/jbmr.354","volume":"26","author":"KA Alexander","year":"2011","unstructured":"Alexander, K. A., et al. (2011). Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 26(7), 1517\u20131532.","journal-title":"Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research"},{"issue":"11","key":"9494_CR84","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1593\/neo.09988","volume":"11","author":"K Mizutani","year":"2009","unstructured":"Mizutani, K., et al. (2009). The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment. Neoplasia, 11(11), 1235\u20131242.","journal-title":"Neoplasia"},{"issue":"12","key":"9494_CR85","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/onc.2012.166","volume":"32","author":"MK Herroon","year":"2013","unstructured":"Herroon, M. K., et al. (2013). Macrophage cathepsin K promotes prostate tumor progression in bone. Oncogene, 32(12), 1580\u20131593.","journal-title":"Oncogene"},{"issue":"10","key":"9494_CR86","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1016\/j.bbagen.2013.06.033","volume":"1830","author":"TH Lin","year":"2013","unstructured":"Lin, T. H., et al. (2013). CCL2 increases alphavbeta3 integrin expression and subsequently promotes prostate cancer migration. Biochimica et Biophysica Acta, 1830(10), 4917\u20134927.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"19","key":"9494_CR87","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1158\/0008-5472.CAN-07-1286","volume":"67","author":"RD Loberg","year":"2007","unstructured":"Loberg, R. D., et al. (2007). Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Research, 67(19), 9417\u20139424.","journal-title":"Cancer Research"},{"issue":"7","key":"9494_CR88","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1593\/neo.07307","volume":"9","author":"RD Loberg","year":"2007","unstructured":"Loberg, R. D., et al. (2007). CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia, 9(7), 556\u2013562.","journal-title":"Neoplasia"},{"issue":"6","key":"9494_CR89","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20080108","volume":"205","author":"T Hagemann","year":"2008","unstructured":"Hagemann, T., et al. (2008). \u201cRe-educating\u201d tumor-associated macrophages by targeting NF-kappaB. Journal of Experimental Medicine, 205(6), 1261\u20131268.","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"9494_CR90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","volume":"19","author":"C Rolny","year":"2011","unstructured":"Rolny, C., et al. (2011). HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell, 19(1), 31\u201344.","journal-title":"Cancer Cell"},{"issue":"5","key":"9494_CR91","doi-asserted-by":"crossref","first-page":"e63451","DOI":"10.1371\/journal.pone.0063451","volume":"8","author":"YR Na","year":"2013","unstructured":"Na, Y. R., et al. (2013). Cyclooxygenase-2 inhibition blocks M2 macrophage differentiation and suppresses metastasis in murine breast cancer model. PLoS One, 8(5), e63451.","journal-title":"PLoS One"},{"issue":"5","key":"9494_CR92","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bjc.6605814","volume":"103","author":"JD Veltman","year":"2010","unstructured":"Veltman, J. D., et al. (2010). Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma. British Journal of Cancer, 103(5), 629\u2013641.","journal-title":"British Journal of Cancer"},{"issue":"12","key":"9494_CR93","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1582-4934.2009.00926.x","volume":"14","author":"M Coscia","year":"2010","unstructured":"Coscia, M., et al. (2010). Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. Journal of Cellular and Molecular Medicine, 14(12), 2803\u20132815.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"9","key":"9494_CR94","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrclinonc.2011.72","volume":"8","author":"G Lorenzo Di","year":"2011","unstructured":"Di Lorenzo, G., Buonerba, C., & Kantoff, P. W. (2011). Immunotherapy for the treatment of prostate cancer. Nature Reviews. Clinical Oncology, 8(9), 551\u2013561.","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"11","key":"9494_CR95","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1002\/art.27645","volume":"62","author":"S Djaafar","year":"2010","unstructured":"Djaafar, S., et al. (2010). Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice. Arthritis and Rheumatism, 62(11), 3300\u20133310.","journal-title":"Arthritis and Rheumatism"},{"issue":"9","key":"9494_CR96","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.4049\/jimmunol.1101855","volume":"189","author":"A Sawant","year":"2012","unstructured":"Sawant, A., et al. (2012). Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. Journal of Immunology, 189(9), 4258\u20134265.","journal-title":"Journal of Immunology"},{"issue":"12","key":"9494_CR97","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/nm1201-1339","volume":"7","author":"W Zou","year":"2001","unstructured":"Zou, W., et al. (2001). Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nature Medicine, 7(12), 1339\u20131346.","journal-title":"Nature Medicine"},{"issue":"5","key":"9494_CR98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri3442","volume":"13","author":"D Masopust","year":"2013","unstructured":"Masopust, D., & Schenkel, J. M. (2013). The integration of T cell migration, differentiation and function. Nature Reviews Immunology, 13(5), 309\u2013320.","journal-title":"Nature Reviews Immunology"},{"issue":"4","key":"9494_CR99","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/01.bor.0000231909.35043.da","volume":"18","author":"PG Fournier","year":"2006","unstructured":"Fournier, P. G., Chirgwin, J. M., & Guise, T. A. (2006). New insights into the role of T cells in the vicious cycle of bone metastases. Curr Opin Rheumatology, 18(4), 396\u2013404.","journal-title":"Curr Opin Rheumatology"},{"issue":"5","key":"9494_CR100","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10875-009-9316-6","volume":"29","author":"T Nakashima","year":"2009","unstructured":"Nakashima, T., & Takayanagi, H. (2009). Osteoimmunology: crosstalk between the immune and bone systems. Journal of Clinical Immunology, 29(5), 555\u2013567.","journal-title":"Journal of Clinical Immunology"},{"issue":"9","key":"9494_CR101","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.4049\/jimmunol.0803897","volume":"182","author":"JR Kiesel","year":"2009","unstructured":"Kiesel, J. R., Buchwald, Z. S., & Aurora, R. (2009). Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. Journal of Immunology, 182(9), 5477\u20135487.","journal-title":"Journal of Immunology"},{"key":"9494_CR102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.2009.05303.x","volume":"1192","author":"H Takayanagi","year":"2010","unstructured":"Takayanagi, H. (2010). New immune connections in osteoclast formation. Annals of the New York Academy of Sciences, 1192, 117\u2013123.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"14","key":"9494_CR103","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1158\/0008-5472.CAN-10-3922","volume":"71","author":"K Zhang","year":"2011","unstructured":"Zhang, K., et al. (2011). CD8+ T cells regulate bone tumor burden independent of osteoclast resorption. Cancer Research, 71(14), 4799\u20134808.","journal-title":"Cancer Research"},{"key":"9494_CR104","doi-asserted-by":"crossref","unstructured":"Bidwell, B. N., et al. (2012). Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nature Medicine, 18, 1224\u20131231.","DOI":"10.1038\/nm.2830"},{"issue":"2","key":"9494_CR105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4161\/onci.1.2.18480","volume":"1","author":"E Zhao","year":"2012","unstructured":"Zhao, E., et al. (2012). Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. Oncoimmunology, 1(2), 152\u2013161.","journal-title":"Oncoimmunology"},{"issue":"8","key":"9494_CR106","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell, B. N., et al. (2012). Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med, 18(8), 1224\u20131231.","journal-title":"Nat Med"},{"key":"9494_CR107","doi-asserted-by":"crossref","unstructured":"Pappalardo, A., Thompson, K. (2013). Activated gammadelta T cells inhibit osteoclast differentiation and resorptive activity in vitro. Clinical and Experimental Immunology, 174, 281\u2013291.","DOI":"10.1111\/cei.12165"},{"issue":"6","key":"9494_CR108","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2003-05-1655","volume":"102","author":"F Dieli","year":"2003","unstructured":"Dieli, F., et al. (2003). Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood, 102(6), 2310\u20132311.","journal-title":"Blood"},{"issue":"2","key":"9494_CR109","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10555-010-9223-6","volume":"29","author":"DG DeNardo","year":"2010","unstructured":"DeNardo, D. G., Andreu, P., & Coussens, L. M. (2010). Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Reviews, 29(2), 309\u2013316.","journal-title":"Cancer Metastasis Reviews"},{"issue":"2","key":"9494_CR110","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr3412","volume":"15","author":"LD Roy","year":"2013","unstructured":"Roy, L. D., et al. (2013). Arthritis augments breast cancer metastasis: role of mast cells and SCF\/c-Kit signaling. Breast Cancer Research, 15(2), R32.","journal-title":"Breast Cancer Research"},{"issue":"2","key":"9494_CR111","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2141.2004.05024.x","volume":"126","author":"S Bord","year":"2004","unstructured":"Bord, S., et al. (2004). Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. British Journal of Haematology, 126(2), 244\u2013251.","journal-title":"British Journal of Haematology"},{"issue":"5","key":"9494_CR112","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bone.2006.05.019","volume":"39","author":"MA Kacena","year":"2006","unstructured":"Kacena, M. A., Gundberg, C. M., & Horowitz, M. C. (2006). A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone, 39(5), 978\u2013984.","journal-title":"Bone"},{"issue":"4","key":"9494_CR113","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jcb.22456","volume":"109","author":"WA Ciovacco","year":"2010","unstructured":"Ciovacco, W. A., et al. (2010). Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. Journal of Cellular Biochemistry, 109(4), 774\u2013781.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"1","key":"9494_CR114","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jbmr.204","volume":"26","author":"X Li","year":"2011","unstructured":"Li, X., et al. (2011). Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 26(1), 125\u2013134.","journal-title":"Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research"},{"issue":"6","key":"9494_CR115","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjh.12328","volume":"161","author":"VR Deutsch","year":"2013","unstructured":"Deutsch, V. R., & Tomer, A. (2013). Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. British Journal of Haematology, 161(6), 778\u2013793.","journal-title":"British Journal of Haematology"},{"issue":"2","key":"9494_CR116","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay, L. J., & Felding-Habermann, B. (2011). Contribution of platelets to tumour metastasis. Nature Reviews Cancer, 11(2), 123\u2013134.","journal-title":"Nature Reviews Cancer"},{"issue":"17","key":"9494_CR117","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1182\/blood-2009-10-247296","volume":"115","author":"L Erpenbeck","year":"2010","unstructured":"Erpenbeck, L., & Schon, M. P. (2010). Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood, 115(17), 3427\u20133436.","journal-title":"Blood"},{"issue":"4","key":"9494_CR118","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1172\/JCI113411","volume":"81","author":"S Karpatkin","year":"1988","unstructured":"Karpatkin, S., et al. (1988). Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. The Journal of Clinical Investigation, 81(4), 1012\u20131019.","journal-title":"The Journal of Clinical Investigation"},{"issue":"24","key":"9494_CR119","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.1073\/pnas.2234372100","volume":"100","author":"SJ Bakewell","year":"2003","unstructured":"Bakewell, S. J., et al. (2003). Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proceedings of the National Academy of Sciences of the United States of America, 100(24), 14205\u201314210.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"9494_CR120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10585-012-9561-6","volume":"30","author":"JL Sottnik","year":"2013","unstructured":"Sottnik, J. L., et al. (2013). Integrin alpha2beta 1 (alpha2beta1) promotes prostate cancer skeletal metastasis. Clinical and Experimental Metastasis, 30(5), 569\u2013578.","journal-title":"Clinical and Experimental Metastasis"},{"key":"9494_CR121","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-4598-11-66","volume":"11","author":"A Gupta","year":"2012","unstructured":"Gupta, A., Cao, W., & Chellaiah, M. A. (2012). Integrin alphavbeta3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2\/Smad 5\/receptor activator of NF-kappaB ligand signaling axis. Molecular Cancer, 11, 66.","journal-title":"Molecular Cancer"},{"issue":"10","key":"9494_CR122","doi-asserted-by":"crossref","first-page":"e3535","DOI":"10.1371\/journal.pone.0003535","volume":"3","author":"TE King","year":"2008","unstructured":"King, T. E., et al. (2008). The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model. PLoS One, 3(10), e3535.","journal-title":"PLoS One"},{"key":"9494_CR123","doi-asserted-by":"crossref","unstructured":"Kerr, B. A., et al. (2013) Platelets govern pre-metastatic tumor communication to bone. Oncogene, 32, 4319\u20134324.","DOI":"10.1038\/onc.2012.447"},{"issue":"3","key":"9494_CR124","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrc747","volume":"2","author":"PW Mantyh","year":"2002","unstructured":"Mantyh, P. W., et al. (2002). Molecular mechanisms of cancer pain. Nature Reviews Cancer, 2(3), 201\u2013209.","journal-title":"Nature Reviews Cancer"},{"issue":"2","key":"9494_CR125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.abb.2008.03.016","volume":"473","author":"F Elefteriou","year":"2008","unstructured":"Elefteriou, F. (2008). Regulation of bone remodeling by the central and peripheral nervous system. Archives of Biochemistry and Biophysics, 473(2), 231\u2013236.","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"1","key":"9494_CR126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bone.2010.07.009","volume":"48","author":"T Yoneda","year":"2011","unstructured":"Yoneda, T., et al. (2011). Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone, 48(1), 100\u2013105.","journal-title":"Bone"},{"issue":"6142","key":"9494_CR127","doi-asserted-by":"crossref","first-page":"1236361","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon, C., et al. (2013). Autonomic nerve development contributes to prostate cancer progression. Science, 341(6142), 1236361.","journal-title":"Science"},{"issue":"1","key":"9494_CR128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.eururo.2007.03.054","volume":"52","author":"T Mistry","year":"2007","unstructured":"Mistry, T., et al. (2007). Obesity and prostate cancer: a role for adipokines. European Urology, 52(1), 46\u201353.","journal-title":"European Urology"},{"issue":"7","key":"9494_CR129","doi-asserted-by":"crossref","first-page":"e1001363","DOI":"10.1371\/journal.pbio.1001363","volume":"10","author":"JP Campbell","year":"2012","unstructured":"Campbell, J. P., et al. (2012). Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biology, 10(7), e1001363.","journal-title":"PLoS Biology"},{"issue":"5","key":"9494_CR130","doi-asserted-by":"crossref","first-page":"E507","DOI":"10.1152\/ajpendo.00191.2012","volume":"304","author":"H Kondo","year":"2013","unstructured":"Kondo, H., Takeuchi, S., & Togari, A. (2013). beta-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species. American Journal of Physiology, Endocrinology and Metabolism, 304(5), E507\u2013E515.","journal-title":"American Journal of Physiology, Endocrinology and Metabolism"},{"issue":"2","key":"9494_CR131","first-page":"874","volume":"123","author":"S Hassan","year":"2013","unstructured":"Hassan, S., et al. (2013). Behavioral stress accelerates prostate cancer development in mice. The Journal of Clinical Investigation, 123(2), 874\u2013886.","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"9494_CR132","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/pros.22564","volume":"73","author":"HH Grytli","year":"2013","unstructured":"Grytli, H. H., et al. (2013). Use of beta-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy. Prostate, 73(3), 250\u2013260.","journal-title":"Prostate"},{"issue":"4","key":"9494_CR133","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jtbi.2006.12.004","volume":"245","author":"P Macklin","year":"2007","unstructured":"Macklin, P., & Lowengrub, J. (2007). Nonlinear simulation of the effect of microenvironment on tumor growth. Journal of Theoretical Biology, 245(4), 677\u2013704.","journal-title":"Journal of Theoretical Biology"},{"key":"9494_CR134","volume-title":"Cancer bioinformatics: from therapy design to treatment","author":"S Nagl","year":"2005","unstructured":"Nagl, S. (2005). Cancer bioinformatics: from therapy design to treatment. Chichester: Wiley."},{"key":"9494_CR135","volume-title":"Computational biology of cancer: lecture notes and mathematical modeling","author":"D Wodarz","year":"2008","unstructured":"Wodarz, D., & Komarova, N. L. (2008). Computational biology of cancer: lecture notes and mathematical modeling. Hackensack: World Scientific."},{"issue":"3","key":"9494_CR136","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1057\/jos.2010.3","volume":"4","author":"CM Macal","year":"2010","unstructured":"Macal, C. M., & North, M. J. (2010). Tutorial on agent-based modelling and simulation. Journal of Simulation, 4(3), 151\u2013162.","journal-title":"Journal of Simulation"},{"key":"9494_CR137","volume-title":"A new kind of science","author":"S Wolfram","year":"2002","unstructured":"Wolfram, S. (2002). A new kind of science. Champaign: Wolfram Media."},{"key":"9494_CR138","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/978-3-540-30479-1_46","volume":"3305","author":"B Ribba","year":"2004","unstructured":"Ribba, B., et al. (2004). The use of hybrid cellular automaton models for improving cancer therapy. Lecture Notes in Computer Science, 3305, 444\u201353.","journal-title":"Lecture Notes in Computer Science"},{"key":"9494_CR139","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7643-8123-3","volume-title":"Single-cell-based models in biology and medicine","author":"ARA Anderson","year":"2007","unstructured":"Anderson, A. R. A., Chaplain, M. A. J., & Rejniak, K. A. (2007). Single-cell-based models in biology and medicine. Basel: Birkh\u00e4user."},{"issue":"17","key":"9494_CR140","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1158\/0008-5472.CAN-08-3957","volume":"69","author":"D Basanta","year":"2009","unstructured":"Basanta, D., et al. (2009). The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach. Cancer Research, 69(17), 7111\u20137120.","journal-title":"Cancer Research"},{"issue":"2","key":"9494_CR141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bone.2010.04.601","volume":"47","author":"P Pivonka","year":"2010","unstructured":"Pivonka, P., & Komarova, S. V. (2010). Mathematical modeling in bone biology: from intracellular signaling to tissue mechanics. Bone, 47(2), 181\u2013189.","journal-title":"Bone"},{"issue":"5","key":"9494_CR142","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.081229","volume":"24","author":"MD Ryser","year":"2009","unstructured":"Ryser, M. D., Nigam, N., & Komarova, S. V. (2009). Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 24(5), 860\u2013870.","journal-title":"Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research"},{"issue":"10","key":"9494_CR143","doi-asserted-by":"crossref","first-page":"e1002703","DOI":"10.1371\/journal.pcbi.1002703","volume":"8","author":"MD Ryser","year":"2012","unstructured":"Ryser, M. D., Qu, Y., & Komarova, S. V. (2012). Osteoprotegerin in bone metastases: mathematical solution to the puzzle. PLoS Computational Biology, 8(10), e1002703.","journal-title":"PLoS Computational Biology"}],"updated-by":[{"DOI":"10.1007\/s10555-014-9507-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000}}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-014-9494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-014-9494-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-014-9494-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T01:15:09Z","timestamp":1716426909000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-014-9494-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,12]]},"references-count":143,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9494"],"URL":"https:\/\/doi.org\/10.1007\/s10555-014-9494-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10555-014-9507-3","asserted-by":"object"}]},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,12]]}}}